Cardio Diagnostics Holdings, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD -5.46 M

Cardio Diagnostics Holdings, Inc. EBITDA is USD -5.46 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -43.68% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Cardio Diagnostics Holdings, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -9.70 M.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)